Upgrade to SI Premium - Free Trial

Teva Pharma (TEVA) PT Raised to $50 at JPMorgan

October 12, 2026 5:30 AM
JPMorgan analyst Chris Schott raised the price target on Teva Pharma (NYSE: TEVA) to $50.00 (from $40.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change